Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceMen's health

Rye Pollen Extract (Cernilton)

A standardised rye-grass pollen extract with a long European history in prostate care: it improves self-reported symptoms and nocturia but consistently fails to change any objective measure — urine flow, residual volume, or prostate size. Its strongest single trial is actually in chronic prostatitis, not BPH.

What the science says

  • Relieves BPH symptoms and nocturia Limited evidence

    A Cochrane review of four studies in 444 men (12-24 weeks) found Cernilton roughly doubled the odds of self-rated improvement (RR 2.40) and of nocturia improvement (RR 2.05) versus placebo or comparator. The review was later withdrawn for not being updated, and the underlying trials were small, short, and mostly unblinded by modern standards.

  • Improves objective urinary measures Limited evidence

    The same pooled analysis found no improvement in peak urine flow rate, residual urine volume, or prostate size — a pattern that suggests symptom-scale change without a measurable change in bladder outlet function. That dissociation is the single most important honest caveat about this product.

  • Reduces chronic prostatitis/chronic pelvic pain (CP/CPPS) Moderate evidence

    A multicentre, double-blind, placebo-controlled phase 3 trial in 139 men with inflammatory CP/CPPS gave two capsules three times daily for 12 weeks and reported a larger fall in total NIH-CPSI score and a significantly greater improvement in the pain subscore than placebo, with about 70% versus 50% responders. This is the best single trial of the extract, but it remains one study in a condition notorious for large placebo responses.

  • Shrinks the prostate or lowers PSA Limited evidence

    No trial has shown any effect on prostate volume or PSA. Proposed mechanisms are anti-inflammatory and smooth-muscle relaxant rather than hormonal, so this is not a substitute for finasteride, dutasteride, or an alpha-blocker.

Dosage & safety

Studied doseStandard trial dosing is two tablets of the Cernilton preparation three times daily — roughly 375-500 mg/day of pollen extract, supplying the water-soluble Cernitin T60 and lipid-soluble GBX fractions — for 12-24 weeks. The 12-week mark is when trials assessed response; shorter courses have not been evaluated. Generic "flower pollen extract" products are not necessarily the same standardised material used in the research.
SafetyAdverse effects in trials were mild and comparable to placebo, mainly nausea and abdominal discomfort; withdrawal rates were low. The obvious caution is allergy — this is a pollen product, and people with grass pollen or rye allergy, or with a history of anaphylaxis to bee/flower pollen products, should avoid it. Reported hypersensitivity reactions include urticaria and, rarely, more severe responses. Long-term safety beyond about six months is undocumented. As with all prostate herbs, symptoms that are new, worsening, or accompanied by blood in the urine, fever, or inability to void warrant medical assessment rather than self-treatment, and no herb here removes the need for PSA and digital rectal examination decisions made with a clinician.

Scientific references

Where to buy

Theralogix, Prostate PQ, 180 Tablets

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Men's health